Why the study?
Elucidating the regulatory mechanisms of cardiac aging is a challenge, yet necessary to protect against age-related diseases, extend lifespan, and reduce cardiovascular disease burden in elderly individuals.
Answers are grounded in this paper and cite their sources.
This narrative review synthesizes the core molecular mechanisms of cardiac aging—including oxidative stress, mitochondrial dysfunction, autophagy, telomere damage, noncoding RNAs, and mTOR signaling—and evaluates emerging preclinical and clinical therapeutic strategies such as caloric restriction, rapamycin, and cell therapy.
With research progress on longevity, we have gradually recognized that cardiac aging causes changes in heart structure and function, including progressive myocardial remodeling, left ventricular hypertrophy, and decreases in systolic and diastolic function. Elucidating the regulatory mechanisms of cardiac aging is a great challenge for biologists and physicians worldwide. In this review, we discuss several key molecular mechanisms of cardiac aging and possible prevention and treatment methods developed in recent years. Insights into the process and mechanism of cardiac aging are necessary to protect against age-related diseases, extend lifespan, and reduce the increasing burden of cardiovascular disease in elderly individuals. We believe that research on cardiac aging is entering a new era of unique significance for the progress of clinical medicine and social welfare.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2021) conducted a review in Cardiac aging. Caloric restriction, cell therapy, rapamycin, and emerging pharmacotherapies (metformin, nicotinamide derivatives, spermidine, agelastatin A) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: